Product Description
| Brand | Wondfo |
| Sample Type | Serum/ Plasma/ WB |
| Pack Size | 25T |
| CAT No | W203 |
| Biomarker | Cardiac |
The Finecare cTn I Rapid Quantitative Test is a fluorescence immunoassay used along with Finecare FIA System for quantitative determination of cardiac troponin I (cTn I) in human whole blood, serum or plasma. This test is used as an aid to assist in the diagnosis of acute myocardial infarction (AMI).
Reliable and Rapid cTnI QuantificationFinecare cTn I Rapid Quantitative Test enables rapid and accurate measurement of cardiac troponin I, a key biomarker for acute myocardial infarction. Results are available in approximately 15 minutes, supporting timely clinical decisions and critical patient care. Its high sensitivity and quantitative range assure healthcare professionals of dependable insights when every second counts.
User-Friendly Professional DesignThis test is designed for hospitals and clinical laboratories, featuring ready-to-use cassettes and an easy workflow that integrates seamlessly with the Finecare FIA Meter. The digital display, combined with lightweight and portable cassettes, ensures flexible deployment in various healthcare settings with minimal training required.
Advanced Technology, Superior AccuracyLeveraging fluorescence immunochromatography, the test resists interference from common biological substances, providing accuracy over 99% (with the Reader) and a measurement range from 0.1 to 100 ng/mL. Each pack is clearly marked with a lot number for traceability, and the test maintains reliability throughout its 18-month shelf life when stored at 2-30C.
FAQ's of Wondfo Finecare cTn I Rapid Quantitative Test:
Q: How is the Wondfo Finecare cTn I Rapid Quantitative Test used in a clinical setting?
A: The test is used by collecting a sample of whole blood, serum, or plasma and applying it to the cassette. After adding the provided buffer, the cassette is inserted into the Finecare FIA Meter, which analyzes the sample and displays the troponin I (cTnI) concentration within about 15 minutes.
Q: What are the benefits of choosing this test for myocardial infarction diagnosis?
A: This test offers rapid, quantitative, and highly accurate results for cTnI, supporting early and reliable diagnosis of myocardial infarction and acute coronary syndrome. Its resistance to common interferences and high sensitivity helps ensure diagnostic confidence in critical situations.
Q: When should this test be performed during patient care?
A: The test is ideal for use when acute myocardial infarction or acute coronary syndrome is suspected, enabling clinicians to quickly assess troponin I levels and make prompt decisions regarding patient management and treatment.
Q: Where can the Wondfo Finecare cTn I Test be deployed?
A: Designed for flexibility, the lightweight and portable test can be used in hospitals, emergency departments, and clinical laboratories. It supports both stationary and bedside testing, streamlining cardiac biomarker analysis wherever needed.
Q: What is the process for obtaining a test result with this system?
A: Prepare the patient sample, use the cassette and buffer as instructed, and place the cassette into the Finecare Reader. The device will automatically process the sample and provide a quantitative readout of cTnI levels on its digital display in under 15 minutes.
Q: Is any special storage required for the test kits?
A: Yes, kits must be stored at temperatures between 2C and 30C and kept away from direct sunlight to preserve their integrity over the 18-month shelf life.
Q: What makes this test highly accurate and reliable?
A: Its design utilizes fluorescence immunochromatography technology and is resistant to common biological interferences. When used with the Finecare Reader, it delivers greater than 99% accuracy and offers a broad quantitative measurement range, ensuring clinical reliability.